Alcon bought Aerie Pharmaceuticals Aerie Pharmaceuticals from 11/22/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Alcon completed its acquisition of Aerie Pharmaceuticals for $770 million, or 15.25 per share.

Aerie Pharmaceuticals

Review

Source:

{source} pictogram

investor.alcon.com

Vladimir Petenev

News editor

Write your comment first

News feed

Lenta opened a hypermarket ‘Economy’ in Chelyabinsk

12/6/24 LENT

Board of Directors of Perm Energy Supply Company recommended dividends

12/6/24 PMSB

Ozone Pharmaceuticals has launched a generic of Rivaroxaban on the market

12/6/24 OZPH

Positive Technologies has entered the Egyptian market

12/6/24 POSI

Samolet will reduce the pace of withdrawal of facilities in Moscow and the Moscow region

12/6/24 SMLT

Fix Price's board of directors declared a dividend

12/5/24 FIXP

Board of Directors of SmartTech Group proposed an additional share issue to shareholders

12/5/24 CARM

Rostelecom expects ₽1 trillion in revenue by 2030

12/5/24 RTKM

Shareholders of LUKOIL approved dividends

12/5/24 LKOH

Cherkizovo to increase exports to Saudi Arabia

12/5/24 GCHE